Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q2 EPS of ($0.70), $0.01 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $250 thousand versus the consensus estimate of $1.21 million.

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.